Selected article for: "relative difference and sample size"
Title: 2018 ACVIM Forum Research Abstract Program: Seattle, Washington, June 14 - 15, 2018
  • Document date: 2018_10_25
    • ID: 60ceejq1_587
    Snippet: This study suggests that dyslipidemia may not occur in cats with CKD and implies a possible difference in the pathophysiology of CKD in cats relative to that of dogs and humans. Further studies with a larger sample size and cats with more advanced CKD are needed to confirm our findings. available to evaluate the efficacy of drug treatments. In humans, computed tomography (CT) and magnetic resonance imaging (MRI) are used to follow ADPKD progressi.....
    Document: This study suggests that dyslipidemia may not occur in cats with CKD and implies a possible difference in the pathophysiology of CKD in cats relative to that of dogs and humans. Further studies with a larger sample size and cats with more advanced CKD are needed to confirm our findings. available to evaluate the efficacy of drug treatments. In humans, computed tomography (CT) and magnetic resonance imaging (MRI) are used to follow ADPKD progression by evaluating total kidney volume (TKV). The purpose of this study was to examine the efficacy of biomarkers and imaging modalities to evaluate disease progression in feline ADPKD.

    Search related documents:
    Co phrase search for related documents
    • ADPKD progression and feline ADPKD disease progression: 1
    • ADPKD progression and feline ADPKD disease progression evaluate: 1
    • compute tomography and CT compute tomography: 1, 2
    • disease progression and drug treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • disease progression and drug treatment efficacy: 1
    • disease progression and feline ADPKD disease progression: 1
    • disease progression and feline ADPKD disease progression evaluate: 1